Here at Omnicell, we are entering 2025 with a renewed ... with the addition of XT Cabinet automation and the expansion of anesthesia dispensing automation and software in order to support care ...

In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. Omnicell beat analysts’ revenue expectations by 0.6% last quarter, reporting ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

Here are five major anesthesia groups to watch in 2025: US Anesthesia Partners: U.S. Anesthesia Partners is a physician-owned anesthesia management company that works with anesthesiologists, CRNAs and ...

Analyst Allen Lutz of Bank of America Securities maintained a Hold rating on Omnicell (OMCL – Research Report), retaining the price target of $46.00. Allen Lutz has given his Hold rating due to ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...

The Federal Trade Commission has reached a settlement with private equity group Welsh, Carson, Anderson & Stowe in an anti-trust case involving portfolio company U.S. Anesthesia Partners ...

Earlier this year, the state of Colorado reached an agreement with Dallas-based U.S. Anesthesia Partners to resolve an investigation into what the state called an anticompetitive monopoly that ...

A Washington Democrat hopes to study the impact of medical anesthesia on climate change. The goal is to address the environmental impact of the anesthetic gases used in medical, dental and ...

Omnicell, Inc. (NASDAQ:OMCL – Free Report) – Stock analysts at Zacks Research raised their Q2 2025 earnings per share (EPS) estimates for Omnicell in a report released on Tuesday, January 28th.